UK markets open in 58 minutes

Editas Medicine, Inc. (0IFK.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
5.76+0.35 (+6.47%)
At close: 07:13PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.02
52-week change 32.87%
S&P500 52-week change 323.06%
52-week high 311.79
52-week low 30.00
50-day moving average 38.49
200-day moving average 38.69

Share statistics

Avg vol (3-month) 35.91k
Avg vol (10-day) 34.68k
Shares outstanding 547.5M
Implied shares outstanding 6N/A
Float 876.15M
% held by insiders 10.32%
% held by institutions 180.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -196.12%
Operating margin (ttm)-39.90%

Management effectiveness

Return on assets (ttm)-20.87%
Return on equity (ttm)-43.17%

Income statement

Revenue (ttm)78.12M
Revenue per share (ttm)1.03
Quarterly revenue growth (yoy)818.70%
Gross profit (ttm)N/A
EBITDA -163.12M
Net income avi to common (ttm)-153.22M
Diluted EPS (ttm)-2.73
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)323.11M
Total cash per share (mrq)3.95
Total debt (mrq)36.54M
Total debt/equity (mrq)10.47%
Current ratio (mrq)5.39
Book value per share (mrq)4.27

Cash flow statement

Operating cash flow (ttm)-132.18M
Levered free cash flow (ttm)-87.81M